AN2 Therapeutics Inc. Made Headway

Tue, Sep 27, 2022 at 07:33 PM
AN2 Therapeutics Inc. Made Headway

AN2 Therapeutics Inc. (ANTX:NASDAQ) soared at $15.5, a gain of 31.1%. On Tue, Sep 27, 2022, ANTX:NASDAQ hit a New 2-Week High of $15.5. The stock got featured on our News Catalysts scanner on Mon, Aug 29, 2022 at 08:35 AM in the 'MISCELLANEOUS' category. From Tue, Sep 13, 2022, the stock recorded 70.00% Up Days and 72.73% Green Days

About AN2 Therapeutics Inc. (ANTX:NASDAQ)

AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.